In this issue:
Therapies for chronic GVHD
Therapies for advanced CTCL
Lutikizumab for HS
Remibrutinib for HS
FRONTIER-2: JNJ-77242113 for plaque psoriasis
DELTA-3: delgocitinib for chronic hand eczema
Upadacitinib for non-segmental vitiligo
AEs with JAK inhibitors
Atopic dermatitis & childhood growth
Maternal HS & offspring outcomes
Please login below to download this issue (PDF)